AstraZeneca's Farxiga approved by US FDA for type-2 diabetes patients aged 10 and older.

AstraZeneca's Farxiga treatment has been approved by the US FDA to treat type-2 diabetes patients aged 10 and older. Previously approved for adults, this expansion extends the drug's use as an adjunct to diet and exercise for glycemic control. Further regulatory submissions and rollout plans are under consideration.